Papers
1
Total Citations
3
H-Index
1
About
Dr. Wenji Li is a pioneering urologic surgeon whose research focuses on minimally invasive surgical techniques for complex renal pathologies, particularly robot-assisted partial nephrectomy. Dr. Li’s major contribution lies in demonstrating the feasibility and safety of the retroperitoneal approach for managing giant renal hilum angiomyolipomas (AMLs)—rare, life-threatening tumors that encase critical hilar vessels and the ureter. Their landmark 2022 case report, which has garnered 3 citations, provides a detailed surgical roadmap for resecting these challenging masses while preserving renal function, addressing a critical gap in urologic oncology. This work highlights Dr. Li’s expertise in pushing the boundaries of robotic surgery to treat conditions that previously required radical nephrectomy or carried high hemorrhagic risks. By showcasing a successful outcome for a giant hilar AML, Dr. Li has offered a reproducible technique that reduces morbidity and expands treatment options for patients with complex renal tumors. Their research is particularly impactful for surgeons seeking to adopt advanced robotic approaches for rare, high-stakes cases, and it underscores Dr. Li’s role in advancing the frontier of nephron-sparing surgery.
Research Focus
Key Achievements
Top Papers
- 1